The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere

Jing Li(Ludwig-Maximilians-Universität München), Dehua Yu(Zhejiang Chinese Medical University)
Journal of Translational Medicine
October 2, 2013
Cited by 79


Related Papers